IP Library Granted Patent US 11,674,186
Granted Patent B2
US 11,674,186 · App. 17/110,985 · Granted Jun 13, 2023

Synthetic nucleic acid control molecules

Inventors: Ilse A. Tyler (Poway, CA); Keith Yaeger (Verona, WI); Michael J. Domanico (Middleton, WI); Hatim Allawi (Middleton, WI); Graham P. Lidgard (Middleton, WI)
Assignee: Exact Sciences Corporation
C12Q1/6886C12N15/11C12Q1/6876C12Q2600/154C12Q2600/156C12Q2600/166
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,674,186
App. No.
17/110,985
Granted
Jun 13, 2023
Kind
B2
Abstract

The present invention provides synthetic DNA strands that find use as controls or in nucleic acid testing methods. In particular, provided herein are synthetic DNA strands of known composition for use as control molecules in stool DNA testing, e.g., of mutations and/or methylation of DNA isolated from stool samples.

Claims (10)

1. A run control composition, comprising:

a) a number of copies of a first synthetic DNA fragment comprising a sequence of a portion of a human biomarker DNA, wherein the sequence is synthesized to comprise a sequence region containing a number and pattern of cytosines and cytosine-phosphate-guanosine (CpG) dinucleotides in which each of the cytosines in the CpG dinucleotides in the pattern comprises a 5-methyl;

b) a number of copies of a second synthetic DNA fragment comprising the same sequence of the same portion of the human biomarker DNA as the first synthetic DNA, and comprising a sequence region comprising the same number and pattern of cytosines and CpG dinucleotides as the sequence region in the first synthetic DNA fragment, wherein none of the cytosines in the pattern comprises a 5-methyl; and

c) fish DNA.

2. The run control composition of claim 1 , wherein the first synthetic DNA fragment and the second synthetic DNA fragment are double-stranded.

3. The run control composition of claim 1 , wherein the first and second synthetic DNA fragments each further comprise a second sequence region containing a CpG dinucleotide in which the cytosine does not comprise a 5-methyl.

4. The run control composition of claim 1 , wherein the composition comprises at least 50 μg/mL fish DNA.

5. The run control composition of claim 1 , further comprising a DNA stabilization buffer comprising Tris-HCl, EDTA, and NaCl.

6. The run control composition of claim 5 , wherein the DNA stabilization buffer is 80% of the volume of the composition, and wherein the DNA stabilization buffer comprises 500 mM Tris-HCl, 150 mM EDTA, and 10 mM NaCl, pH 9.

7. The run control composition of claim 1 , further comprising a synthetic DNA fragment comprising a sequence from a human reference gene.

Assignments (3)
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2022
From: TYLER, ILSE A; YAEGER, KEITH; DOMANICO, MICHAEL J; ALLAWI, HATIM T; LIDGARD, GRAHAM P
To: EXACT SCIENCES CORPORATION
Reel/Frame 060533/0635 →
MERGER Recorded Jan 14, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 058738/0465 →